Qube Research & Technologies (QRT)’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
JGCM
Qube Research & Technologies (QRT)'s PJP Position: Q2 2026 in Review
Qube Research & Technologies (QRT) reduced its Invesco Pharmaceuticals ETF (PJP) stake by 65% in Q2 2026, selling an estimated $3.68K and leaving 18 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.
Qube Research & Technologies (QRT) first reported a position in PJP in Q2 2021 and has held it in 20 quarters since. The position peaked at $317K in Q3 2023. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- Qube Research & Technologies (QRT) held 18 shares of Invesco Pharmaceuticals ETF worth $2.13K as of Q2 2026.
- Qube Research & Technologies (QRT) sold 34 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $3.68K.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3366 holding.
- Qube Research & Technologies (QRT) first reported a position in Invesco Pharmaceuticals ETF in Q2 2021 and has held it in 20 quarters since.
- Qube Research & Technologies (QRT)'s Invesco Pharmaceuticals ETF position peaked at $317K in Q3 2023.
- 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.